Dolca Thomas
Director/Board Member bei ALLAKOS INC.
Vermögen: - $ am 31.03.2024
Profil
Dr. Dolca Thomas, MD, is an Independent Director at UCB SA, an Independent Director at Allakos, Inc. and a Venture Partner at Samsara Biocapital LLC.
He is on the Board of Directors at UCB SA, Allakos, Inc., Ventus Therapeutics U.S., Inc. and Ventus Therapeutics, Inc. Dr. Thomas was previously employed as a Chief Medical Officer, EVP-Research & Development by Equillium, Inc., an Independent Director by Chinook Therapeutics, Inc., a Chief Medical Officer by Principia Biopharma, Inc., a VP & Global Head-Translational Medicine by Roche Group, a Vice President-Clinical Development by Pfizer Inc., and a Director-Global Clinical Development by Bristol Myers Squibb Co. He also served on the board at Juvenile Diabetes Research Foundation and PML Computer Centre Pty Ltd.
He received his undergraduate degree from Cornell University and a doctorate degree from Cornell University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
ALLAKOS, INC.
-.--% | 01.08.2023 | 0 ( -.--% ) | - $ | 31.03.2024 |
Aktive Positionen von Dolca Thomas
| Unternehmen | Position | Beginn |
|---|---|---|
| ALLAKOS INC. | Director/Board Member | 31.07.2023 |
| UCB | Director/Board Member | 25.04.2024 |
Ventus Therapeutics, Inc.
 Ventus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ventus Therapeutics, Inc. operates as a biopharmaceutical company. It focuses in developing novel small molecule medicines that target the innate immune system to treat autoimmune diseases, inflammatory diseases and cancer. The company was founded by Hao Wu, Richard Flavell, Judy Lieberman, Thomas Tuschl, and Feng Shao and is headquartered in Montreal, Canada. | Director/Board Member | 01.09.2021 |
Ventus Therapeutics U.S., Inc.
 Ventus Therapeutics U.S., Inc. Medical DistributorsDistribution Services Ventus Therapeutics U.S., Inc. operates as a biotechnology company. The company is headquartered in Natick, MA. | Director/Board Member | 07.12.2021 |
Samsara Biocapital LLC
 Samsara Biocapital LLC Investment ManagersFinance Samsara Biocapital LLC (Samsara Biocapital) is an independent venture capital firm founded in 2016 by Srinivas Akkaraju. The firm is headquartered in Palo Alto, California. | Private Equity Investor | 01.05.2023 |
Ehemalige bekannte Positionen von Dolca Thomas
| Unternehmen | Position | Ende |
|---|---|---|
| CHINOOK THERAPEUTICS, INC. | Director/Board Member | 11.08.2023 |
| EQUILLIUM, INC. | Chief Tech/Sci/R&D Officer | 01.02.2022 |
| PRINCIPIA BIOPHARMA INC. | Chief Tech/Sci/R&D Officer | 28.09.2020 |
Roche Group
 Roche Group Real Estate DevelopmentFinance Roche Group manages real estate properties. The company designs, develops and constructs residential, commercial and industrial properties. It also provides property management services. The company is headquartered in Basel, Switzerland. | Corporate Officer/Principal | 01.09.2018 |
| ░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Ausbildung von Dolca Thomas
| Cornell University | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 5 |
|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| PFIZER, INC. | Health Technology |
| UCB | Health Technology |
| ALLAKOS INC. | Health Technology |
| EQUILLIUM, INC. | Health Technology |
| Private Unternehmen | 8 |
|---|---|
Principia Biopharma, Inc.
 Principia Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Principia Biopharma, Inc. is a biopharmaceutical company, which engages in designing and developing oral therapies to patients with significant unmet medical needs in immunology and oncology. It operates through Tailored Covalency platform, which enables to develop small molecule inhibitors of enzymes and receptor ligands with potencies and selectivities that rival those of injectable biologics, yet maintain the convenience of a pill. Its product pipeline includes PRN1008, PRN2246, PRN1371, and immunoproteasome inhibitor. The company was founded by Jack Taunton and Richard A. Miller on October 6, 2008 and is headquartered in South San Francisco, CA. | Health Technology |
Roche Group
Roche Group Real Estate DevelopmentFinance Roche Group manages real estate properties. The company designs, develops and constructs residential, commercial and industrial properties. It also provides property management services. The company is headquartered in Basel, Switzerland. | Finance |
Samsara Biocapital LLC
Samsara Biocapital LLC Investment ManagersFinance Samsara Biocapital LLC (Samsara Biocapital) is an independent venture capital firm founded in 2016 by Srinivas Akkaraju. The firm is headquartered in Palo Alto, California. | Finance |
Juvenile Diabetes Research Foundation
 Juvenile Diabetes Research Foundation Miscellaneous Commercial ServicesCommercial Services Juvenile Diabetes Research Foundation operates an organization focused on treating and preventing diabetes. The private company is based in Shrewsbury. | Commercial Services |
Ventus Therapeutics, Inc.
Ventus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ventus Therapeutics, Inc. operates as a biopharmaceutical company. It focuses in developing novel small molecule medicines that target the innate immune system to treat autoimmune diseases, inflammatory diseases and cancer. The company was founded by Hao Wu, Richard Flavell, Judy Lieberman, Thomas Tuschl, and Feng Shao and is headquartered in Montreal, Canada. | Health Technology |
Ventus Therapeutics U.S., Inc.
Ventus Therapeutics U.S., Inc. Medical DistributorsDistribution Services Ventus Therapeutics U.S., Inc. operates as a biotechnology company. The company is headquartered in Natick, MA. | Distribution Services |
Chinook Therapeutics, Inc.
 Chinook Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Chinook Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in discovering, developing, and commercializing precision medicines for rare, severe chronic kidney diseases. The company was founded in 2019 and is headquartered in Seattle, WA. | Health Technology |
PML Computer Centre Pty Ltd.
 PML Computer Centre Pty Ltd. Electronics/Appliance StoresRetail Trade PML Computer Centre Pty Ltd. engages in the provision of retail and corporate IT products and services. The company is headquartered in Melbourne, Australia. | Retail Trade |
